Regulatory Perspectives on Emerging Technologies for Now and Beyond

As we battle the current pandemic, the global population is leaning heavily now more than ever on the life sciences industry and looking for guidance from the FDA to navigate the crisis and beyond. As the former Acting Inspector General at the Department of Justice and Director of CDER Compliance, Cynthia will share perspectives on the role of quality during this pandemic and how FDA is evolving to embrace change and emerging technology in an effort to advance quality and safety objectives.